Here's the live share price of Panacea Biotec along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Panacea Biotec has gained 16.73% CAGR. Over the past year, the corresponding return has been 29.10%.
Panacea Biotec’s current P/E of 238.34x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Panacea Biotec | 4.02 | 9.47 | 4.38 | 8.54 | 28.54 | 47.40 | 16.63 |
Sun Pharmaceutical Industries | 2.06 | 0.64 | -0.29 | -6.05 | -10.36 | 23.39 | 25.71 |
Divi's Laboratories | 1.05 | -1.46 | -7.06 | 5.17 | 11.12 | 18.85 | 12.67 |
Cipla | 0.77 | 0.55 | 4.98 | 4.26 | -4.78 | 14.98 | 14.28 |
Torrent Pharmaceuticals | -0.37 | -2.36 | 10.54 | 13.75 | 6.15 | 34.09 | 19.94 |
Dr. Reddy's Laboratories | 1.19 | 4.36 | 0.47 | 13.24 | 0.40 | 17.18 | 4.36 |
Mankind Pharma | 0.32 | 5.47 | 10.65 | 21.36 | 8.69 | 22.30 | 12.84 |
Zydus Lifesciences | -0.27 | 5.49 | 8.66 | 15.24 | -3.58 | 42.49 | 20.53 |
Lupin | 2.76 | 3.76 | 4.60 | 0.40 | -8.13 | 47.13 | 13.49 |
Abbott India | 0.05 | -5.02 | -1.64 | 4.00 | 11.49 | 21.25 | 13.42 |
Alkem Laboratories | 1.44 | 2.36 | 13.95 | 13.72 | -10.12 | 19.04 | 13.89 |
Aurobindo Pharma | 0.49 | 2.30 | 0.72 | -1.94 | -27.54 | 28.97 | 6.12 |
Glenmark Pharmaceuticals | -1.55 | 6.06 | 26.14 | 43.64 | 27.29 | 78.11 | 32.71 |
Laurus Labs | 2.11 | 5.59 | 37.74 | 55.72 | 88.44 | 21.66 | 25.06 |
Biocon | 0.30 | 0.21 | 6.66 | 8.57 | 0.36 | 7.96 | -4.26 |
Anthem Biosciences | 3.86 | 6.40 | 16.66 | 16.66 | 16.66 | 5.27 | 3.13 |
GlaxoSmithKline Pharmaceuticals | -4.19 | -1.64 | -16.46 | -1.72 | -1.84 | 24.81 | 10.06 |
Cohance Lifesciences | -8.25 | 1.56 | -9.31 | -19.42 | -20.26 | 25.68 | 18.71 |
Ipca Laboratories | 1.13 | -4.16 | -2.60 | -1.43 | -8.12 | 15.67 | 4.08 |
Gland Pharma | 1.73 | 1.41 | 15.34 | 26.45 | 8.53 | -3.79 | 1.89 |
Over the last one year, Panacea Biotec has gained 28.54% compared to peers like Sun Pharmaceutical Industries (-10.36%), Divi's Laboratories (11.12%), Cipla (-4.78%). From a 5 year perspective, Panacea Biotec has outperformed peers relative to Sun Pharmaceutical Industries (25.71%) and Divi's Laboratories (12.67%).
Day | SMA | EMA |
---|---|---|
5 | 425.99 | 427.7 |
10 | 418.05 | 422.75 |
20 | 412.63 | 418.43 |
50 | 415.71 | 421.32 |
100 | 450.59 | 426.48 |
200 | 431.62 | 405.22 |
In the latest quarter, Panacea Biotec remained same as its previous close in promoter holding, while DII stake increased to 1.52%, FII holding fell to 0.79%, and public shareholding moved up to 25.20% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 08, 2025, 11:27 PM IST | Panacea Biotec L - Demat Status Report For The Month Of August 2025 |
Sep 08, 2025, 10:08 PM IST | Panacea Biotec L - Business Responsibility and Sustainability Reporting (BRSR) |
Sep 08, 2025, 10:04 PM IST | Panacea Biotec L - Reg. 34 (1) Annual Report. |
Sep 08, 2025, 9:51 PM IST | Panacea Biotec L - Intimation Of 41St Annual General Meeting Of The Company To Be Held On Tuesday, September 30, 2025 At 11:3 |
Aug 14, 2025, 11:55 PM IST | Panacea Biotec L - Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For |
Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 309.85 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Panacea Biotec is ₹446.75 as on Sep 18, 2025.
The Panacea Biotec is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Panacea Biotec is ₹2,736.07 Cr as on Sep 18, 2025.
Today’s highest and lowest price of Panacea Biotec are ₹467.90 and ₹446.70.
The 52-week high/low is the highest and lowest price at which Panacea Biotec stock has traded in the past 52-week or nearly a year. The 52-week high of Panacea Biotec is ₹581.00 and 52-week low of Panacea Biotec is ₹259.40 as on Sep 18, 2025.
The Panacea Biotec has shown returns of -2.52% over the past day, 9.95% for the past month, 4.84% over 3 months, 29.1% over 1 year, 47.61% across 3 years, and 16.73% over 5 years.
P/E ratio of and PB ratio of Panacea Biotec are 238.34 and 3.28 on Sep 18, 2025. While the company gives a dividend yield of 0.00 per annum.